Home › NDC Lookup › RxCUI directory › RxCUI 2168867

Evening Dosing 24 HR methylphenidate hydrochloride 20 MG Extended Release Oral Capsule [Jo... — RxCUI 2168867

Name: Evening Dosing 24 HR methylphenidate hydrochloride 20 MG Extended Release Oral Capsul… (RxCUI 2168867)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic branded drug

RxCUI 2168867 Semantic branded drug · SBD ● Current RxNorm concept 5 FDA products 5 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2168867

Official nameEvening Dosing 24 HR methylphenidate hydrochloride 20 MG Extended Release Oral Capsule [Jornay]

Concept typeSemantic branded drug (SBD)

RxNorm statusCurrent RxNorm concept

Also known asJornay PM 20 MG 24HR Extended Release Oral Capsule; Evening Dosing 24 HR Jornay 20 MG Extended Release Oral Capsule

FDA products mapped5

Package NDCs mapped5

Reported Medicaid activity (SDUD)277,408 prescriptions · 49 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Methylphenidate Transdermal Patch: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Yes, location matters. Apply the patch to the hip area — not the waist, arm, or back. The clinical studies that established how well and how safely the patch works were done specif...
Where exactly do I put the patch and does it matter?
Water exposure — from bathing, swimming, or showering — can affect how well the patch sticks. If the patch partially or fully comes off, don't try to re-stick it with tape or adhes...
Can my child shower or swim while wearing the patch?

📖 Read our full Methylphenidate Transdermal Patch guide →

🕸️ Concept Web — How Evening Dosing 24 HR methylphenidate hydrochlori... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Evening Dosing 24 HR methylphenidate hydrochloride 20 MG Extended Release Oral Capsule [Jornay] RxCUI 2168867 Semantic branded drug · SBD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 2

The active substance itself — no strength, form, or brand attached yet.
- Methylphenidate 6901 IN
- Methylphenidate hydrochloride 203188 PIN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Jornay 2168839 BN
Dose forms 13

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Methylphenidate Extended Release Oral Capsule 374655 SCDF
- Methylphenidate hydrochloride Extended Release Oral Capsule 2647476 SCDFP
- Methylphenidate Oral Product 1163482 SCDG
- Methylphenidate Pill 1163483 SCDG
- Methylphenidate hydrochloride Oral Product 2661865 SCDGP
- Methylphenidate hydrochloride Pill 2659123 SCDGP
- Methylphenidate Extended Release Oral Capsule [Jornay] 2168841 SBDF
- Methylphenidate hydrochloride Extended Release Oral Capsule [Jornay] 2655018 SBDFP
- +5 more in this family
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Evening Dosing 24 HR methylphenidate hydrochloride 20 MG Extended Release Oral Capsule 2168866 SCD
- Methylphenidate hydrochloride 20 MG 1091160 SCDC
- Methylphenidate hydrochloride 20 MG [Jornay] 2168846 SBDC

Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Evening Dosing 24 HR methylphenidate hydrochloride 20 MG Extended Release Oral Capsule SCD · 2168866
Methylphenidate hydrochloride 20 MG SCDC · 1091160
Methylphenidate Extended Release Oral Capsule SCDF · 374655
Methylphenidate hydrochloride Extended Release Oral Capsule SCDFP · 2647476
Methylphenidate Oral Product SCDG · 1163482
Methylphenidate Pill SCDG · 1163483
Methylphenidate hydrochloride Oral Product SCDGP · 2661865
Methylphenidate hydrochloride Pill SCDGP · 2659123

Brand-Name Concepts

Methylphenidate hydrochloride 20 MG [Jornay] SBDC · 2168846
Methylphenidate Extended Release Oral Capsule [Jornay] SBDF · 2168841
Methylphenidate hydrochloride Extended Release Oral Capsule [Jornay] SBDFP · 2655018
Jornay Oral Product SBDG · 2168842
Jornay Pill SBDG · 2168843
Jornay BN · 2168839

📦 FDA Products & Package NDCs

5 products · 5 package NDCs

5 package NDCs map to RxCUI 2168867 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
71376-0201-03	100 CAPSULE in 1 BOTTLE (71376-201-03)	JORNAY PM Extended-Release	Ironshore Pharmaceuticals Inc.	2019-06-01
71376-0202-03	100 CAPSULE in 1 BOTTLE (71376-202-03)	JORNAY PM Extended-Release	Ironshore Pharmaceuticals Inc.	2019-06-01
71376-0203-03	100 CAPSULE in 1 BOTTLE (71376-203-03)	JORNAY PM Extended-Release	Ironshore Pharmaceuticals Inc.	2019-06-01
71376-0204-03	100 CAPSULE in 1 BOTTLE (71376-204-03)	JORNAY PM Extended-Release	Ironshore Pharmaceuticals Inc.	2019-06-01
71376-0205-03	100 CAPSULE in 1 BOTTLE (71376-205-03)	JORNAY PM Extended-Release	Ironshore Pharmaceuticals Inc.	2019-06-01

Observed labelers: Ironshore Pharmaceuticals Inc. (5) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.